as 10-28-2025 4:00pm EST
Stocks
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | BELLEVUE |
| Market Cap: | 13.2M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 2.0M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.85 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.45 - $13.40 | Next Earning Date: | 11-24-2025 |
| Revenue: | $104,735 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
OSRH Breaking Stock News: Dive into OSRH Ticker-Specific Updates for Smart Investing
Newsfile
9 days ago
PR Newswire
15 days ago
PR Newswire
2 months ago
GOBankingRates
5 months ago
GOBankingRates
5 months ago
GOBankingRates
5 months ago
Yahoo Finance
5 months ago
The Guardian
5 months ago
The information presented on this page, "OSRH OSR Holdings Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.